The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate
Portfolio Pulse from Benzinga Newsdesk
The Oncology Institute (NASDAQ:TOI) reported Q1 EPS of $(0.22), missing the $(0.12) estimate, with sales of $94.67M also missing the $95.16M estimate. Despite these misses, both losses and sales showed improvement over the previous year.
May 14, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The Oncology Institute reported a larger than expected quarterly loss and a slight miss in sales, but showed improvement over the previous year.
Missing both EPS and sales estimates typically has a negative short-term impact on a company's stock price. However, the year-over-year improvement in both metrics may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100